# Redx Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/redx-pharma

- Industry: Pharmaceuticals
- Headquarters: Macclesfield, UK
- Website: www.redxpharma.com
- Total disclosed funding: $36M
- Latest round: Series A (Aug 27, 2026)
- Investors on record: 5

## About

Based in the UK, Redx Pharma Limited develops targeted small-molecule medicines for fibrotic disease and cancer. Based in Macclesfield, UK and founded in 2010 by its co-founder Neil Murray, Peter Jackson, Derek Lindsay, Redx Pharma Limited previously known as Redx Pharma Plc, conducts drug discovery and clinical development focused primarily on fibrotic diseases. The company develops small-molecule drug candidates targeting the ROCK pathway and Discoidin Domain Receptors. In August 2026, Redx Pharma Plc raised USD 36 million in series A funding led by Abingworth, with participation from other investors British Business Bank, NextBio,5AM Ventures and Redmile Group. Redx Pharma researches and develops novel small-molecule medicines for fibrosis and cancer. Its pipeline includes Zelasudil (RXC007) for idiopathic pulmonary fibrosis, RXC008 for Crohn's disease-related fibrosis, and RXC004 for cancer treatment. The company also provides drug discovery, translational science, and clinical development expertise. The company generates revenue through research collaborations, licensing agreements, upfront payments, milestone payments, and potential royalties from pharmaceutical partners. Strategic partnerships with companies such as Jazz Pharmaceuticals and AstraZeneca support development programs while providing non-dilutive funding for clinical research and commercialization activities. The company will use the September 2026 funding to support Phase 2 development of RXC008 for fibrostenotic Crohn’s disease.

## Funding rounds

- Series A, Aug 27, 2026, $36M — Abingworth, 5AM Ventures, Redmile Group, NextBio, British Business Bank

## Investors

- Abingworth (https://capitalatlas.ai/funds/abingworth) — Series A
- 5AM Ventures (https://capitalatlas.ai/funds/5am-ventures) — Series A
- Redmile Group (https://capitalatlas.ai/funds/redmile-group) — Series A
- NextBio — Series A
- British Business Bank (https://capitalatlas.ai/funds/british-business-bank) — Series A